English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Amanda Rupp
| Oct 5, 2016
Keynote speakers announced for 2016 Rare Diseases and Orphan Products Breakthrough Summit
Amanda Rupp
| Oct 4, 2016
NOF's online support community surpasses 30,000 members
Amanda Rupp
| Oct 4, 2016
Health leaders release One Brave Idea research award
Amanda Rupp
| Oct 4, 2016
NIH honors 12 environmental health research leaders
Amanda Rupp
| Oct 3, 2016
American Diabetes Association supports FDA approval of hybrid insulin delivery system
Amanda Rupp
| Oct 3, 2016
FDA outlines risks of homeopathic teething gels, tablets
Amanda Rupp
| Oct 3, 2016
Amgen to present new data concerning melanoma, metastatic colorectal cancer treatments
Amanda Rupp
| Oct 2, 2016
FDA approves Ilaris expansion for three rare diseases
Trending
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+
Pharmaceuticals
Patient Daily
| Jun 25, 2025
Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
« First
«
…
2
3
4
5
6
7
8
…
»
Last »